High-dose therapy and autologous stem cell rescue for patients with Hodgkin's disease in first relapse after chemotherapy: Results from the EBMT

Bone Marrow Transplantation

Volumn 20, Issue 9, 1997, Pages 745-752

  Sweetenham, J W ^a   Taghipour, G ^b   Milligan, D ^c   Blystad, A K ^d   Caballero, D ^e   Fassas, A ^f   Goldstone, A H ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^f G PAPANICOLAOU HOSPITAL   (Greece)

Author keywords

ASCT; First relapse; High dose therapy; Hodgkin's disease

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; AUTOTRANSPLANTATION; CANCER SURVIVAL; DRUG MEGADOSE; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; TIME;

EID: 0030710532     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700963     Document Type: Article

References (30)

1. Fisher RI. DeVita VT, Hubbard SP et al. Prolonged disease free survival in Hodgkin's disease with MOPP reinduction after first relapse. Ann Intern Med 1979; 90: 761-763.
2. Viviani S, Santoro A, Negretti E et al. Salvage chemotherapy in Hodgkin's disease. Ann Oncol 1990; 7: 123-127.
3. Bonadonna G, Santoro A, Gianni AM et al. Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience. Ann Oncol 1991; 2 (Suppl. 1): 9-16.
4. Canellos GP, Anderson JR, Propert KJ et al. Chemotherapy of advanced Hodgkin's disease treated with MOPP, ABVD, or MOPP alternating with ABVD. New Engl J Med 1992; 327: 1478-1484.
5. Fairey AF, Mead GM, Jones HW et al. CAPE/PALE salvage chemotherapy for Hodgkin's disease patients relapsing within 1 year of ChlVPP chemotherapy. Ann Oncol 1993; 4: 857-860.
6. Longo DL, Duffey PL, Young RC et al. Conventional dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure. J Clin Oncol 1992; 10: 210-218.
7. Phillips GL, Wolff SN, Herzig RH et al. Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation. Blood 1989; 73: 2086-2092.
8. Reece DE, Barnett MJ, Connors JM et al. Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease. J Clin Oncol 1991; 9: 1871-1879.
9. Bierman PJ, Bagin RG, Jagannath S et al. High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long term follow-up in 128 patients. Ann Oncol 1993; 4: 767-773.
10. Chopra R, McMillan AK, Linch DC et al. The place of high dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single center 8-year study of 155 patients. Blood 1993; 81: 1137-1145.
11. Crump M, Smith AM, Brandwein J et al. High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant. J Clin Oncol 1993; 11: 704-711.
12. Rapoport AP, Rowe JM, Kouides PA et al. One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome. J Clin Oncol 1993; 11: 2351-2361.
13. Nademanee A, O'Donell MR, Snyder DS et al. High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors. Blood 1995; 85: 1381-1390.
14. Bierman PJ, Anderson JR, Freeman MB et al. High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy. Ann Oncol 1996; 7: 151-156.
15. Desch CE, Lasala MR, Smith TJ et al. The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse. J Clin Oncol 1992; 10: 200-209.
16. Reece DE, Connors JM, Spinelli JJ et al. Intensive therapy with cyclophosphamide, carmustine etoposide ± cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy. Blood 1994; 83: 1193-1199.
17. Lister TA, Crowther D, Sutcliffe SB et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989; 7: 1630-1636.
18. De Vita VT, Serpick AA, Carbone PP et al. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 1970; 73: 881-895.
19. Bonnadonna G, Zucali R, Monfardini S et al. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine and imidazole carboxamide vs MOPP. Cancer 1975; 36: 252-259.
20. Wagstaff J, Gregory WM, Swindell R et al. Prognostic factors for survival in stage IIIB and IV Hodkin's disease: a multivariate analysis comparing two specialist treatment centres. Br J Cancer 1988; 46: 487-492.
21. McKendrick JJ, Mead GM, Sweetenham JW et al. ChlVPP chemotherapy in advanced Hodgkin's disease. Ear J Cancer Clin Oncol 1989; 25: 557-563.
22. Klimo P, Connors JM. An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV hybrid program. Semin Hematol 1988; 25 (Suppl. 2): 34-40.
23. Sweetenham JW, Mead GM, Jeffrey GM et al. Twelve weeks alternating chemotherapy for advanced Hodgkin's disease -results of a pilot study. Exp Hematol 1992; 20: 821.
24. Radford JA, Crowther D. Treatment of relapsed Hodgkin's disease using a weekly chemotherapy of short duration: results of a pilot study in 20 patients. Ann Oncol 1991; 2: 505-509.
25. Velasquez WS, Cabanillas F, Salvador P et al. Effective salvage therapy for lymphoma with cisplatin in combination with high dose Ara-C and dexamethasone (DHAP). Blood 1988; 71: 117-122.
26. Santoro A, Viviani S, Valagussa P et al. CCNU, etoposide and prednisolone (CEP) in refractory Hodgkin's disease. Semin Hematol 1986; 13 (Suppl. 1): 23-26.
27. Linch DC, Winfield D, Goldstone AH et al. Dose intensification with autologous bone marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet 1993; 341: 1051-1054.
28. Philip T, Armitage JO, Spitzer G et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high grade non-Hodgkin's lymphoma. New Engl J Med 1987; 316: 1493-1498.
29. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. Am Stat Assoc 1979; 53: 457-481.
30. Brice P, Bastion Y, Divine M et al. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients. Cancer 1996; 78: 1293-1299.